Status:
WITHDRAWN
Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients
Lead Sponsor:
Paul Farand
Conditions:
Scleroderma, Systemic
Hypertension, Pulmonary
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the value in terms of sensitivity, specificity and likelihood ratio of the stress echocardiography in the screening of pulmonary arterial hypertension in patient...
Detailed Description
Pulmonary artery catheterization (rest and exertion) and treadmill stress echocardiography will be done to all patients of the study.
Eligibility Criteria
Inclusion
- At least one of the prespecified indirect sign of pulmonary arterial hypertension
- Able to exercise on treadmill
Exclusion
- left ventricular dysfunction at rest
- Absence of pulmonary regurgitant flow
- Pregnancy or breastfeeding
- Smoking with \> 60 pack-year
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01202045
Start Date
September 1 2010
End Date
October 1 2011
Last Update
July 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre hospitalier universitaire de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4